SPONSOR
University of Regensburg
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: HbS DiseaseHemoglobin S DiseaseSickle Cell AnemiaSickle Cell DisordersSickling Disorder Due to Hemoglobin SSickle Cell DiseasePeritoneal CarcinomatosisTinnitusTinnitus, Bilateral
University of Regensburg is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia, Sickle Cell Disorders.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Regensburg
How many clinical trials has University of Regensburg sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University of Regensburg, of which 3 are actively recruiting participants. These trials cover conditions including HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Regensburg research focus on?
University of Regensburg clinical trials span HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia, Sickle Cell Disorders, Sickling Disorder Due to Hemoglobin S, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Regensburg clinical trial?
To participate in a University of Regensburg trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Regensburg trials with current recruitment status updated daily.
Clinical Trials by University of Regensburg
NCT04201210 Phase 2
Recruiting
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
HbS Disease
NCT04108936
Recruiting
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
Peritoneal Carcinomatosis
NCT07885176
Recruiting
Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
Tinnitus
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology